Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal vaccine response before versus after splenectomy in adults with asplenia
NL-OMON60167Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Prevnar 20 and PCV21 in asplenia (3 arms), sponsored by Leiden University Medical Center. Started Nov 2025; status: recruiting.
02
Drugs
Prevnar 20PCV21
03
Conditions
asplenia
Beyond the preview
Go deeper on NL-OMON60167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60167.